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Background: The growth of aging populations in an increasing number of countries has led to a concomitant
increase in the incidence of chronic diseases. Accordingly, the proportion of older aged patients with oral cavity
and oropharyngeal cancers and comorbidities has also increased. Thus, improvements must be made in the
tolerance and safety of surgical procedures for these patients with complex medical conditions. In this study, we
investigated combined submandibular gland flap and sternocleidomastoid musculocutaneous flap for postoperative
reconstruction in older aged patients with oral cavity and oropharyngeal cancers in terms of surgical methods,
safety, and clinical outcome.
Methods: Between January 2011 and May 2012, 8 patients over the age of 65 years (7 men, 1 woman; aged 66 to
75 years (median, 69.6)) with oral cavity and oropharyngeal cancers underwent combined submandibular gland and
sternocleidomastoid myocutaneous flaps for postoperative reconstruction at Ganzhou Tumor Hospital. All eight
patients had comorbid cardiovascular, cerebrovascular, or chronic respiratory disease or diabetes. Clinical outcomes,
complications, and tolerance to surgical treatment were observed.
Results: Surgical treatment was successful in all eight patients. All submandibular gland flaps survived with
well-mucosalized surfaces and with no complications. During the postoperative follow-up period of 12 to
28 months, no patient developed local recurrence or distant metastasis, and all had good recovery of function and
local contour.
Conclusions: This combined reconstruction technique enables appropriate restoration of oral function, facial
aesthetics and improved quality of life. Further, this technique has several advantages: it is easier to perform,
reduces operation time and surgical risk, causes less surgical injury, and has minor impact on contour. The
technique provides a new and safe reconstruction option for older aged patients with oral cavity and
oropharyngeal cancers.
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A number of major organs are concentrated in the oral
cavity and oropharynx. Surgical removal of oral cavity
and oropharyngeal cancers can lead to facial injury or
even disfigurement and decreased oral functions, includ-
ing speech, mastication, and swallowing. Surgical recon-
struction with skin flap, musculocutaneous flap, and/or
osteo-myocutaneous flap enables oral cancer patients to
achieve appropriate restoration of oral function and fa-
cial aesthetics and a greatly improved quality of life [1,2].
With the gradual aging of society, the proportion of
older aged patients with oral cavity and oropharyngeal
cancers and comorbid cardiovascular disease, diabetes,
chronic respiratory disease, or cerebrovascular disease
has been markedly increasing. Older aged patients with
complex medical conditions may have poor surgical toler-
ance and be unable to undergo lengthy and risky operative
procedures. Conventional reconstructive surgeries with
skin, musculocutaneous, and osteo-myocutaneous flaps
tend to be time-consuming and cause relatively large op-
erative trauma, thus potentially increasing surgical risk.
Moreover, the postoperative recovery of older aged pa-
tients, especially those with comorbid systemic disease,
may be delayed. Therefore, there is an increasing need for
a new reconstruction method to improve the tolerance
and safety of reconstructive surgery [3].
Oral cavity and oropharyngeal cancers most often
metastasize to neck lymph nodes, and neck lymphatic
metastases are most frequently observed in levels I, II,
and III [4]. The submandibular glands are located in
level Ib, where they are surrounded by rich lymphatic
tissues. However, the involvement of submandibular
glands in oral cavity and oropharyngeal cancers is quite
rare, especially in early oral cancers [5,6]. Additionally,
the existence of intraglandular lymph nodes within sub-
mandibular glands continues to be debated [7,8]. Studies
have demonstrated that preservation of the submandibu-
lar gland during neck dissection is oncologically safe in
patients with early oral cancers unless the primary tu-
mor or metastatic regional lymphadenopathy is adher-
ent to the gland [9,10]. It has also been reported that
the submandibular gland can survive and maintain its
integrity and function following surgical transfer and
reimplantation [11,12]. These studies suggest that the
submandibular gland can be used in the surgical re-
construction of oral defects. Therefore, it is of clinical
significance to explore further the feasibility of the sub-
mandibular gland flap for postoperative reconstruction in
patients with early oral cavity and oropharyngeal cancers.
Between January 2011 and May 2012, we performed
reconstructive surgeries for oral defects using combined
submandibular gland and sternocleidomastoid musculo-
cutaneous flaps in eight older aged patients with oral
cavity and oropharyngeal cancers at our facility. In thisstudy, we conducted a retrospective analysis of these pa-
tients and report on the safety, practicality, and clinical
effects of this new reconstruction method.
Methods
Ethics statement
The ethics committee of the Tumor Hospital of Ganzhou
Review Board approved the study protocol (20101201),
and the study was conducted in accordance with the prin-
ciples of the Declaration of Helsinki regarding research in-
volving human subjects. Each of the patients provided
written informed consent to participate after the nature of
the study had been explained to them.
Inclusion and exclusion criteria
Inclusion criteria: (1) over 65 years old; (2) pathologically
confirmed diagnosis of oral cavity cancer or oropharyn-
geal cancer; (3) no cervical lymph node metastasis or no
level I lymphatic metastasis; (4) tumor staging: < T3; (5)
comorbid cardiovascular disease, diabetes, chronic respi-
ratory disease, or cerebrovascular disease; (6) Karnofsky
score: ≥ 80; (7) expected survival: over 1 year; (8) volun-
tarily signed informed consent. Exclusion criteria: (1) bi-
lateral cervical lymph node metastasis; (2) bilateral level I
cervical lymph node metastasis; (3) diseased submandibu-
lar gland; (4) prior neck surgery or neck radiotherapy; (5)
distant metastasis; (6) unable to tolerate surgical operation
due to poor clinical condition.
Clinical data
Between January 2011 and May 2012, combined sub-
mandibular gland and sternocleidomastoid myocuta-
neous flap postoperative reconstruction was performed
in eight patients over 65 years of age (seven men, one
woman; age, 66 to 75 years (median, 69.6)) with oral cavity
and oropharyngeal cancers at Ganzhou Tumor Hospital.
Comorbidities included three cases of hypertension, two
cases of chronic bronchitis, two cases of diabetes mellitus,
and one case of history of cerebral infarction. Detailed
clinical data are presented in Table 1.
Surgical procedure
The surgeries were performed under general anesthesia.
Ipsilateral primary tumor resection and total neck level I
to V lymph node dissection were performed, including
level Ia, ipsilateral floor of mouth, sublingual gland, and
mandibular lingual-side periosteum. Local mandibular re-
section was performed in two patients with gingival car-
cinoma. Following the confirmation of no residual tumor
and no cervical lymph node metastases by intraoperative
frozen-section pathology, submandibular gland flap was
performed to reconstruct the oral defect, and sterno-
cleidomastoid myocutaneous flap was used to reconstruct
the floor of the mouth.









Comorbidities Procedure Repair method
1 Male 68 Lateral border of tongue 4 × 3 Squamous 6 × 5 Primary hypertension Tongue carcinoma resection
plus total neck dissection
Tongue defects repaired with
submandibular gland flap; floor of
mouth repaired with
sternocleidomastoid muscle flap
2 Female 66 Lateral border of tongue 3 × 3 Squamous 5 × 5 Diabetes mellitus Tongue carcinoma resection
plus total neck dissection
Tongue defects repaired with
submandibular gland flap; floor of
mouth repaired with
sternocleidomastoid muscle flap
3 Male 75 Lateral border of tongue 3 × 2 Squamous 5 × 4 Chronic bronchitis Tongue carcinoma resection
plus total neck dissection
Tongue defects repaired with
submandibular gland flap; floor of
mouth repaired with
sternocleidomastoid muscle flap
4 Male 71 Root of tongue 2 × 2 Squamous 4 × 4 Primary hypertension Root-of-tongue carcinoma
resection plus whole neck
dissection
Tongue-root defects repaired with
submandibular gland flap; floor of
mouth repaired with
sternocleidomastoid muscle flap
5 Male 67 Root of tongue 3 × 2 Squamous 5 × 4 Cerebral infarction Root-of-tongue carcinoma
resection plus whole neck
dissection
Tongue-root defects repaired with
submandibular gland flap; floor of
mouth repaired with
sternocleidomastoid muscle flap
6 Male 70 Floor of mouth 2 × 2 Squamous 4 × 4 Primary hypertension Floor-of-mouth cancer
resection plus whole neck
dissection
Floor-of-mouth mucosal defects
repaired with submandibular gland
flap; floor of mouth repaired with
sternocleidomastoid muscle flap
7 Male 78 Gingiva 3 × 3 Squamous 5 × 5 Chronic bronchitis Mandible segmental resection
plus total neck dissection
Mandibular defects repaired with
submandibular flap; floor of mouth
repaired with sternocleidomastoid
muscle flap
8 Male 72 Gingiva 4 × 3 Squamous 6 × 5 Diabetes mellitus Mandible segmental resection
plus total neck dissection
Mandibular defects repaired with





















Figure 1 Submandibular gland flap for reconstruction of root-
of-tongue carcinoma, intraoperative view.
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gland and sternocleidomastoid myocutaneous flap and
reconstruction
During routine neck dissection, a horizontal skin incision
was first made 2 cm below the mandible and carried down
through the subcutaneous tissue and platysma. The sub-
mandibular gland was then dissected free of the surround-
ing structures cranially and caudally, up to the horizontal
branch of the mandible and down to the level of the hyoid
bone. During the preparation of the submandibular gland
flap, the capsule of the submandibular gland was well-
protected.
During level I neck dissection, all lymphatic tissue
and fatty tissue at levels I to V were dissected out,
and frozen-section and paraffin-section pathological
examinations for cancer metastases were subsequently
conducted.
The inferior border of the submandibular gland was
released and separated from the digastric muscle. The
proximal ends of the external maxillary artery and anter-
ior facial vein were identified in the superior border of
the deep surface of the posterior belly of the digastric
muscle and were well-protected. The posterior border of
the submandibular gland was then separated, and the
distal ends of the external maxillary artery and anterior
facial vein were both ligated with no damage to the mar-
ginal mandibular branches of the facial nerve. The su-
perior border of the submandibular gland was released
with its duct severed.
Removal of the primary tumor was routinely per-
formed. The released submandibular gland was then
transferred to the site of the defect for reconstruc-
tion, and the proximal ends of the external maxillary
artery and anterior facial vein were used as pedicles
(Figure 1).
The clavicular end of the sternocleidomastoid was dis-
sected to produce a sternocleidomastoid myocutaneous
flap, and the clavicular end of sternocleidomastoid was
then sutured to the anterior belly of the digastric muscle
and mylohyoid muscle to reconstruct the floor of the
mouth (Figure 2).Radiotherapy
Postoperative radiotherapy was conducted in two pa-
tients with tumors 4 × 3 cm using a linear accelerator
(Siemens AG, Munich, Germany) with 6-MV x-rays. Pa-
tients were treated in a thermoplastic mask with isocen-
ter irradiation. The non-irradiated area was shielded by
an individualized low-melting-point lead shielding. Con-
ventional fractionated radiotherapy was carried out at a
dose of 60 Gy for the primary tumor site and a prophy-
lactic dose of 44 Gy for cervical lymph nodes in 2-Gy
fractions once daily five times per week.Clinical observations
Detailed clinical observations included: postoperative
wound healing, complications, pathological examina-
tions of submandibular, submental and cervical lymph
nodes, postoperative contours of tongue, root of tongue
and floor of mouth, postoperative contour and occlusion
of mandible, restoration of breathing, phonation, swallow-
ing, dehiscence and occlusion, and postoperative shoulder




No patients died from the surgery. All submandibular
gland flaps survived and no complications were ob-
served. Postoperatively, the submandibular glands devel-
oped well-mucosalized surfaces and no significant pain
from gland distension was noted. The operative incisions
healed by first intention in all cases. Both intraoperative
frozen sections and postoperative paraffin sections for
all patients confirmed pathologically no cancer metas-
tasis to any of the 27 dissected level I lymph nodes.
Figure 3 Submandibular gland flap for reconstruction of
tongue cancer. One week postoperatively, surface mucosalization
of the submandibular gland is bright red.
Figure 4 Submandibular gland flap for reconstruction of
gingival cancer. Three months postoperatively, submandibular
gland is essentially the same color as the oral mucosa.
Figure 2 Sternocleidomastoid myocutaneous flap for
reconstruction of roof of mouth, intraoperative view.
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metastasis in the remaining levels in all cases.
Appearance and function
After reconstruction, tongue function recovered well
and the contour was pleasing. No significant impact
on phonation was observed. For reconstruction of the
tongue root, no negative impact on breathing or swallow-
ing and no significant swelling were observed. Tongue
movement was normal, with clear phonation. After floor-
of-mouth reconstruction, no swelling or significant impact
on swallowing, tongue movement, or phonation was ob-
served. Mandibular reconstruction resulted in basically
satisfactory appearance. Range of mouth-opening was nor-
mal, but slight malocclusion was observed. Swallowing
and phonation were both normal. No postoperative shoul-
der dysfunction was found, indicating that separation of
the sternocleidomastoid from the clavicle had not notice-
ably altered shoulder function (Figures 3 and 4).
Follow-up
Postoperative follow-up began at the completion of treat-
ment and ended 31 May 2013. No patient was lost tofollow-up. During the follow-up period of 12 to 28 months,
none of the patients developed local recurrence or lymph-
atic or distant metastases.
Discussion
To date there has been no consensus about preservation
of the submandibular gland during neck dissection in
oral cavity and oropharyngeal cancers. Traditional surgi-
cal treatment includes excision of the submandibular
gland and the surrounding lymphatic tissue in addition
to removal of the primary lesion. Submandibular glands
are frequently excised as part of neck dissection. With
the development of functional surgery, an increasing
number of investigations have demonstrated that cancer
metastasis to the submandibular gland is quite rare and
that it is feasible and oncologically safe to preserve the
submandibular gland with no involvement of cancer
metastases during neck dissection followed by close post-
operative follow-up. Whether to preserve the subman-
dibular gland depends on the following conditions: (1)
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nodes; (2) whether it is involved in the primary cancer;
and (3) whether the vessels of the submandibular gland
are left intact during level I neck dissection.
The existence of intraglandular lymph nodes within
the submandibular gland currently remains controversial
[5,6]. Because of their doubts about the existence of in-
traglandular lymph nodes, Rouviere and Tobies as well
as DiNardo performed pathological studies to investigate
intraglandular lymph nodes using human submandibular
gland tissue sections from cadavers. In both studies, no
intraglandular lymph nodes were identified in the sub-
mandibular gland samples [4,6]. Other investigations
have reported similar results [13,14]. Even if there were
intraglandular lymph nodes, the lymphatic drainage of
intraglandular lymph nodes might not be truly identical
to that of the lymph nodes outside the submandibular
gland capsule because of the difference in anatomic struc-
ture between the submandibular gland and submandibu-
lar triangle. Moreover, whether lymph from surrounding
lymphatic tissue can be directed into intraglandular lymph
nodes is less clear and requires further study. Conversely,
numerous studies have suggested that although metastatic
lymph nodes rarely invade the gland, metastasis to level Ib
occurs frequently in oral cavity cancer [15,16]. Hence, al-
though there is no universal consensus about the exist-
ence of intraglandular lymph nodes thus far, it is generally
believed that they do not exist within the submandibular
gland.
Head and neck carcinoma, especially oral cancer, sel-
dom metastasizes to the salivary glands. If it occurs, the
parotid gland is more likely to be affected than the sub-
mandibular gland [17]. Although oral cancer most often
metastasizes to neck lymph nodes and levels I, II, and III
are the most frequently involved [4], the involvement of
the submandibular gland in oral cancers is extremely
rare [5,6]. In a study investigating whether and how head
and neck squamous carcinoma metastasizes to the sub-
mandibular gland, Spiegel et al. demonstrated that, be-
cause of the absence of intraglandular lymph nodes
among 196 examined submandibular glands, in no case
did a squamous cell carcinoma metastasize to the sub-
mandibular gland [8]. The authors found that the sub-
mandibular gland was involved only in cases in which
the primary tumor was in close proximity to the gland,
or when metastasis to level I of the neck had occurred
by extension from a locally affected lymph node into the
submandibular gland. Byeon et al. reported in 2009 that
of 201 cases of oral cavity squamous cell carcinoma, only
two (1%) had carcinomatous involvement in the subman-
dibular gland through direct extension from a primary le-
sion and no submandibular glands showed pathological
evidence of isolated metastasis or local extension of me-
tastatic lymph nodes. Based on their study findings, theauthors thought that it might be feasible and safe to pre-
serve an oncologically sound submandibular gland during
neck dissection in patients with early-stage oral cancer
[18]. Other studies revealed similar results, demonstrating
that submandibular gland metastasis from head and neck
primary squamous cell carcinoma was extremely rare and
that direct invasion as a primary mechanism of metastasis
led to most of the metastases [6,7,9,10]. These studies
concluded that preservation of the submandibular gland
might be oncologically safe and feasible unless there was
evidence of direct invasion of the gland or close proximity
of the cancer to it. Taken together, head and neck carcin-
oma, especially early-stage oral cancer, can be character-
ized by extremely rare metastasis to the submandibular
glands. This metastasis profile provides a solid oncological
basis for the use of the preserved submandibular gland as
reconstruction material.
Submandibular glands are located in level Ib, surroun-
ded by rich lymphatic tissue. The important question is
whether this preparatory procedure in creation of a sub-
mandibular gland flap is technically feasible; that is whe-
ther all lymph nodes in level Ib can be eradicated while
leaving the submandibular gland intact for reconstruc-
tion during neck dissection. More recently, Dhiwakar
et al. performed an anatomic pathological study to de-
termine whether all lymph nodes in level Ib can be extir-
pated without removing the submandibular gland [19].
The authors reported that complete removal of lymph
nodes in level Ib was achieved in all 30 neck dissections
and that the submandibular gland and surgical bed con-
tained no residual lymph nodes. They concluded that, in
suitable cases, it was technically feasible to remove all
level Ib lymph nodes and preserve the submandibular
gland.
The next question is whether the submandibular gland
can survive and maintain its integrity and function follow-
ing transplantation. Survival of the transplanted subman-
dibular gland is crucial to this reconstruction method. It is
clearly unwise to select a submandibular gland as a candi-
date for reconstruction material if it fails to survive follow-
ing transplantation. To prevent xerostomia and protect
the submandibular gland from radiation damage, Seikaly
et al. performed surgical transfer of the submandibular
gland to the submental space outside the proposed radi-
ation field in patients with head and neck carcinoma and
carried out long-term postoperative follow-up. The au-
thors reported that the transferred submandibular glands
survived and maintained salivary function for statistically
significant prevention of xerostomia, and that there were
no disease recurrences on the side of the transferred gland
or in the submental space [11]. Al-Qahtani K et al. con-
ducted a prospective clinical trial in which the subman-
dibular gland was similarly transferred to the submental
space. Their results also suggested that the submandibular
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surgical transplantation [20].
Therefore, based on these above-mentioned findings,
we believe that using the submandibular gland flap to
reconstruct oral defects is oncologically safe and feasible
in patients with early oral cavity and oropharyngeal can-
cers. In this study, we preserved the ipsilateral subman-
dibular gland during neck dissection and reconstructed
oral defects using the transferred submandibular gland
in eight patients. Surgeries were successful in all eight
patients and there were no resulting deaths. All subman-
dibular gland flaps survived with well-mucosalized sur-
faces. No complications were observed. The operative
incisions healed by primary intention in all eight cases.
Twenty-seven lymph nodes were dissected out of level I
in all patients. Pathological examinations of intraopera-
tive frozen sections and postoperative paraffin sections
confirmed no cancer metastases to any of the 27 lymph
nodes. No cancer metastasis was found in the remaining
levels in any patient. No patient developed local relapse
or lymphatic or distant metastasis during the follow-up
period of 12 to 28 months.
As a reconstruction material, the submandibular gland
has several major advantages. First, its abundant blood
supply and a consistent, bulky vascular pedicle make it
difficult for the flap to develop necrosis following trans-
plantation. Second, a submandibular gland flap is easy to
obtain and prepare. Its preparation requires no special
surgical skills and can be completed during neck dissec-
tion. A submandibular gland flap can be easily prepared
for use upon completion of neck dissection. The key
points of the operation are to use care to keep the cap-
sule of the submandibular gland intact and to protect
the proximal and distal ends of the external maxillary ar-
tery and anterior facial vein during preparation. Third,
this method does not require vascular anastomosis. The
relatively simple anatomic structure of the submandibu-
lar gland facilitates the preparation of a submandibular
gland flap in less time than conventional methods. Ad-
ditionally, neck dissection and flap preparation can be
performed as a single-stage procedure, which simplifies
the operation and reduces operative duration. Finally,
the simplified procedure and shorter duration result
in fewer traumas, lower complication rates, and, conse-
quently, decreased surgical risk.
Given that a submandibular gland flap cannot com-
pletely fill the oral defect because of its limited size,
in this study we conducted a combined reconstruction
using a submandibular gland flap for oral and oropharyn-
geal defects and a sternocleidomastoid myocutaneous flap
for floor-of-mouth defects. Similar to a submandibular
gland flap, a sternocleidomastoid myocutaneous flap
is easy to obtain and prepare and does not require a
complex surgical procedure. Therefore, this combinedreconstructive technique can greatly minimize surgical
trauma and operating time.
These advantages suggest that this reconstructive tech-
nique may be the preferred treatment option in suitable
cases, especially in older aged patients with complicated
systemic disease. In the present study, all eight patients
had comorbid cardiovascular disease, cerebrovascular dis-
ease, diabetes, or chronic respiratory disease that made
our patients poor candidates for lengthy and risky surgical
procedures. Thus, we performed reconstructive surgery
using combined submandibular gland and sternocleido-
mastoid myocutaneous flaps.
Our preliminary results were encouraging. Surgery was
successful in all eight patients, with no surgical deaths and
no complications. Compared with the conventional me-
thod we previously used, this combined reconstruction
method shortened operative duration by about 30% on
average. The cosmetic and functional outcomes were sat-
isfactory in all eight patients. Reconstruction of the tongue
resulted in good recovery of tongue function, a pleasing
contour, and no significant impact on phonation. After re-
construction of the tongue root, no negative impact on
breathing or swallowing and no significant swelling were
observed. Tongue movement was normal and phonation
was clear. Floor-of-mouth reconstruction resulted in no
swelling and no significant impact on swallowing, tongue
movement, or phonation. Appearance after mandibular
reconstruction was basically satisfactory; range of mouth
opening was normal although there was slight malocclu-
sion. However, swallowing and phonation were both nor-
mal. No significant postoperative shoulder dysfunction
was noted, suggesting that the separation of the sterno-
cleidomastoid from the clavicle did not greatly alter this.
Appropriate restoration of oral function and facial aesthet-
ics greatly improved the quality of life of these older aged
patients.
Despite its advantages, there are several disadvantages
to this reconstruction method. First, safety is an under-
lying concern. To the best of our knowledge, no large
multicenter clinical study - particularly a prospective
study - has been conducted to prove that intraglandular
lymph nodes do not exist within the submandibular
glands or that the submandibular gland cannot be in-
volved in oral cavity and oropharyngeal cancers through
lymphatic metastasis. Thus, only in cases in which no
neck or level I lymphatic metastases are confirmed pa-
thologically should the submandibular gland be used for
reconstruction. This limits the clinical application of this
technique in a considerable number of patients. A sec-
ond disadvantage is the limited length of the vascular
pedicle. If the proximal ends of the anterior facial artery
and vein are used as vascular pedicles, the submandibular
gland flap can extend only 2.0 ± 7.0 cm away from donor
site because of the length limitation of the pedicle [21]. If
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used as vascular pedicles, the reach of this flap can be im-
proved to some extent with blood supply to the trans-
ferred submandibular gland from the reverse flow of the
external maxillary artery and anterior facial vein. A third
disadvantage is the reconstruction range. The maximal re-
construction range is equal to the maximal cross-section
of the submandibular gland [22], so the submandibular
gland flap cannot cover a larger defect [15]. A final disad-
vantage concerns submandibular gland secretions. It has
been reported that the denervated submandibular gland
maintains long-term secretory function [13,16]. In this re-
construction method, the transferred submandibular
gland is denervated once it is completely detached from
surrounding tissue during flap preparation, and about half
of the submandibular gland is exposed in the oral cavity
after completion of the reconstruction. Little is known
about whether the exposure in the oral cavity has an im-
pact on secretory function of the denervated gland. If the
exposure has little or no impact and salivary function after
denervation is preserved, the submandibular gland may
develop swelling and pain after reconstructive surgery
since the submandibular ducts have been severed during
flap preparation. In this study, because of the limitations
in lengths of vascular pedicles and ranges of reconstruc-
tion, we performed the reconstruction only for oral can-
cers in the posterior two-thirds of the tongue and both
sides of the floor of mouth, gingival cancer adjacent to the
molars, and oropharyngeal cancer close to the tongue.
The maximal reconstruction range was 6 × 5 cm.
We note several limitations to this study. The number
of patients in this study was relatively small and the
follow-up period relatively short, and thus far no pro-
spective randomized comparative clinical study has been
conducted to confirm the feasibility of this combined re-
construction technique in a large number of patients.
Therefore, the long-term clinical effects, safety, and ap-
plication scope of this technique need to be further eval-
uated with adequate statistical power in future clinical
practice.
Conclusions
Skin flap, musculocutaneous flap, and osteo-myocutaneous
flap are conventional methods of postoperative reconstruc-
tion in patients with oral cavity and oropharyngeal cancers.
However, older aged patients with oral cavity and oropha-
ryngeal cancers tend to have comorbid conditions. Older
aged patients with this complex medical condition have
poor surgical tolerance and thus cannot undergo a lengthy
and potentially risky surgical operation. Our combined re-
construction technique with submandibular gland flap and
sternocleidomastoid myocutaneous flap has the advantages
of being easier to perform, causing less surgical injury and
only minor impact on contour, and greatly reducingoperation time and surgical risk. This technique can facili-
tate the restoration of oral function and facial aesthetics
and greatly improve the quality of life of older aged pa-
tients. Hence, this technique can provide a new and safe
reconstruction option for older aged cancer patients with
complex medical conditions. If we can verify at the mo-
lecular level the absence of intraglandular lymph nodes
and that there is no lymphatic metastasis to the subman-
dibular glands, this combined reconstruction technique
may gain popularity.
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